ROP vs SER · P/E 41, rev $1.88B vs rev $56.0K
Roper Technologies, Inc. (ROP) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
ROP currently screens at market cap $61.61B and trailing P/E 41.3. SER currently screens at market cap $29.7M.
Not investment advice. Open the ROP and SER stock pages for the full models.
Not investment advice.